HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$0.32
Day range
$0.29 - $0.33
Year range
$0.22 - $4.79
Market cap
13.37M USD
Avg Volume
4.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.12M | 8.64% |
Net income | -15.43M | -23.79% |
Net profit margin | — | — |
Earnings per share | -0.37 | -85.00% |
EBITDA | -16.12M | -8.67% |
Effective tax rate | 0.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.25M | -33.12% |
Total assets | 49.12M | -32.55% |
Total liabilities | 14.08M | 10.97% |
Total equity | 35.05M | — |
Shares outstanding | 41.26M | — |
Price to book | 0.35 | — |
Return on assets | -70.62% | — |
Return on capital | -95.25% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.43M | -23.79% |
Cash from operations | -15.51M | -49.44% |
Cash from investing | — | — |
Cash from financing | 104.00K | — |
Net change in cash | -15.57M | -54.20% |
Free cash flow | -10.24M | -65.07% |
About
Founded
2011
Website
Employees
52
